fphcare.co.nz

What fphcare.co.nz does

Fisher & Paykel Healthcare Limited is a New Zealand-headquartered medical device company listed on the NZX (NZE: FPH), founded in 1971 and operating globally with 5,001-10,000 employees. It designs, manufactures, and markets respiratory care and humidification products for two primary end-markets: hospital acute care (adult respiratory support, neonatal/infant respiratory care, surgical humidification) and homecare (sleep apnea therapy, home humidified high-flow therapy). Its core technology is heated humidification combined with nasal high flow (NHF) delivery, anchored by the proprietary Optiflow NHF platform capable of delivering up to 100% oxygen at flow rates up to 70 L/min, supported by patents and clinical evidence accumulated over more than 50 years.

The product ecosystem is broad and integrated: hospital devices (F&P Airvo 2 and Airvo 3 NHF systems, F&P 850 and F&P 950 humidifiers, SH870 surgical humidification), neonatal devices (Neopuff T-Piece Resuscitator, Bubble CPAP System, Optiflow Junior 2), an extensive hospital and homecare mask portfolio (F&P Nova Nasal, Nova Micro, Evora Full, Brevida, Eson 2, Simplus, Vitera, Pilairo Q, FlexiFit series, Opus 360, Zest, Forma), CPAP hardware (F&P SleepStyle, HC150 humidifier), interfaces and consumables (breathing circuits, chambers, Optiflow+ and 3S cannulas, RT302, AirSpiral tubing), and a software/data layer (InfoSmart, InfoSmart Web, myMask App, myAirvo). Proprietary features include Evaqua technology for reducing condensate in invasive ventilation circuits, MicroPillows cushion, and SwingFit headgear.

The business model is B2B medical device sales: revenue is generated through hardware sales (devices and capital equipment) plus recurring consumables and accessories (breathing circuits, chambers, masks, cannulas) sold through direct field sales to hospitals and a global distributor network across 30+ countries, with localized websites for the US, Canada, UK, France, Germany, Spain, Italy, Australia, New Zealand, Japan, Korea, India, Brazil, and Russia. Pricing is quote-based via healthcare sales representatives and distributors and is not publicly disclosed. Marketing leverages clinical education (F&P Education Hub, Infant Care Learning Center, Micro Moments video series) and thought-leadership partnerships (The Incubator neonatal podcast).

Name

fphcare.co.nz

Legal name

Fisher & Paykel Healthcare Limited

Website

https://fphcare.co.nz

Company type

Public

Founded year

1970

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Fisher & Paykel Healthcare Limited is a New Zealand-based publicly traded medical device company (NZX: FPH) specializing in heated humidification systems, nasal high-flow therapy devices, CPAP masks, and neonatal respiratory products sold globally to hospitals and homecare patients across 30+ countries.

Ownership category

akta.pro rank

Product category

Respiratory Care Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)

akta.pro secondary industries

Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA), Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG), Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD)

Keywords

• Respiratory care devices
• Nasal high flow therapy
• Medical humidification systems
• Sleep apnea masks
• Neonatal respiratory support

Headquarters

HQ city

Auckland

HQ country

New Zealand

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Sale of respiratory support devices, humidifiers, nasal high flow systems, CPAP devices, and masks for hospital and homecare use. Products include Airvo systems, F&P 950/850 humidifiers, Optiflow therapy systems, and PAP masks. Revenue generated through direct sales to healthcare institutions and through distributor networks globally.
2. Consumables and Accessories: Ongoing sales of disposable products including breathing circuits, chambers, nasal cannula, masks, and accessories for both hospital and homecare therapy systems.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Fisher & Paykel Healthcare designs, manufactures, and markets medical devices for respiratory care, including heated humidification systems, nasal high flow therapy devices (Optiflow, Airvo), CPAP machines, an extensive range of PAP masks, and neonatal/infant respiratory support equipment. Products serve both hospital acute care settings (invasive and noninvasive ventilation, surgical humidification, perianesthesia, NICU) and homecare patients (sleep apnea therapy, home humidified high flow).

Product overview

Fisher & Paykel Healthcare offers a comprehensive portfolio of healthcare technologies for respiratory care spanning hospital and home settings. The product ecosystem centers on nasal high flow therapy systems (Airvo 2, Airvo 3, Optiflow), advanced humidification devices (F&P 850, F&P 950), and a extensive range of CPAP/sleep apnea masks (Nova Nasal, Nova Micro, Evora, Brevida, Eson, Simplus, Vitera, Pilairo, Zest, Forma, FlexiFit series) paired with CPAP devices (SleepStyle) and data management software (InfoSmart, InfoSmart Web, myMask App). Hospital offerings include adult respiratory therapy (invasive and noninvasive ventilation), infant/neonatal care products (Neopuff, Bubble CPAP, Optiflow Junior, neonatal resuscitation equipment), and surgical humidification (SH870). The portfolio is designed to address respiratory support across the care continuum from acute hospital settings to home-based chronic therapy.

Differentiator

Problem solved

Functional benefit

Brands

• Optiflow: Nasal High Flow therapy system for adult respiratory care
• F&P Airvo
• F&P Nova Nasal
• F&P Nova Micro
• F&P 950 System
• F&P SleepStyle
• F&P Solo
• F&P Evora Full
• F&P Eson 2
• F&P Brevida
• F&P Simplus
• F&P Vitera
• Bubble CPAP System
• Neopuff
• Optiflow THRIVE
• myAirvo
• myMask App
• InfoSmart

Products and services

• F&P Airvo 3 System Next-generation Optiflow nasal high flow therapy system with integrated battery for intra-hospital transport, high-pressure oxygen input, and broader flow range. Compatible with wide range of interfaces for adult respiratory support in hospital settings.
• Optiflow NHF System Nasal high flow system delivering up to 100% oxygen at flow rates up to 70 L/min to optimize oxygenation for patients in the perianesthesia environment, including general anesthesia, procedural sedation, and postanesthesia care.
• F&P 850 System

Quantifiable outcome

• Delivers up to 100% oxygen at flow rates up to 70 L/min
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• The IncubatorsupportingGTM or Marketing PartnerFisher & Paykel Healthcare collaborates with The Incubator, a global podcast platform, to share expert-led neonatal care discussions that bring positive change to the industry. This partnership supports thought leadership and clinical education marketing initiatives.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Medtronic: Diversified global medical device incumbent with respiratory, patient monitoring, and hospital capital equipment offerings that intersect F&P's acute-care and homecare segments as part of a much broader portfolio.
• GE HealthCare: Large incumbent providing hospital ICU equipment, anesthesia delivery, and patient monitoring. Competes for hospital capital budgets that fund F&P's NHF, humidification, and ventilation sales.

Emerging players

• Masimo: Specializes in non-invasive patient monitoring (including pulse oximetry and respiration monitoring). Adjacent overlap with F&P's hospital respiratory monitoring and connectivity, particularly in neonatal and ICU settings.

Regional players

• Invacare: Long-standing homecare durable medical equipment provider with overlap in home respiratory therapy distribution. Comparable go-to-market in homecare channels but with broader mobility/O2 product focus rather than humidified NHF specialization.

Direct peers

• Drägerwerk: German medical/safety technology company with strong hospital ventilation, anesthesia gas delivery, and neonatal care portfolios. Overlaps with F&P's Airvo, Optiflow THRIVE, and neonatal respiratory lines.
• ResMed: Global leader in sleep apnea/CPAP devices and masks. Directly competes with FPH's SleepStyle CPAP and Nova/Evora/Brevida mask lines in the OSA homecare market and shares the recurring-consumables revenue model.
• Getinge: Provides ICU/mechanical ventilation, anesthesia, and respiratory support equipment used in the same hospital settings as F&P. Competes for the same hospital formulary and capital-equipment budgets.
• Hamilton Medical: Specialist in mechanical ventilators and intelligent ventilation technologies for ICUs and transport. Direct overlap with F&P's invasive ventilation, NIV, and humidification ecosystem.
• Vyaire Medical: Pure-play respiratory care company offering ventilation, airway management, and respiratory diagnostics. Comparable focus on hospital respiratory workflows and consumables.
• Koninklijke Philips (Respironics): Major CPAP, BiPAP, hospital ventilation, and respiratory耗材 competitor through its Respironics franchise. Competes head-to-head in both homecare sleep apnea and hospital NIV/invasive ventilation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/fphcare
• Facebookfacebook.com/fphcare

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds5 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about fphcare.co.nz